SAV - for SAVvy Investors

So, the SAV Disclosure Document has finally been released and it seems as though they’re looking to raise a fair chunk of change.

You have to be pretty ballsy and have plenty of confidence in your ability to raise capital to attempt to raise $13-$16m without an underwriter in the current environment. However, with the management team they’ll have on board, I reckon they’ll raise the maximum amount without raising a sweat. Not that my measly investment (assuming it’s accepted) will make much of a difference, but I’ll definitely be looking to participate.

I haven’t had time to have an in-depth look at the document but at first glance it seems as though this deal with Emefcy is going to be a real company maker for SAV.

Water is an enormously valuable commodity and wars will be fought over water before all is said and done. The Israelis have proven that they have probably more brain power than any nation on earth (definitely per capita if not absolutely). They have enormous water problems in Israel so it’s logical that the brainiacs over in that neck of the woods would come up with a solution. The Israelis are leaders in desalination as well as so many other cleantech and general technologies.

The Emefcy CEO, Eytan Levy and CTO, Ronen Shechter, have done it all before in the same space with AqWise. You’d think they’re even older and wiser now. The Yank team of Richard Irving and Ross Haghighat have also done it all before and wouldn’t have got involved in Emefcy had they not seen billion dollar potential.

SAV already has billionaire Bori Liberman as a major shareholder and it will be interesting to see who else of note they attract to the register.

I haven’t had time to really dig into the technology but the EBR technology looks like it could be a serious game changer. From the prospectus:
EBR - The Electrogenic Bioreactor (under development): EBR is a technology which is under development which Emefcy believes has the capacity to efficiently and cost effectively harvest electricity generated by bacteria used to treat highly-loaded industrial wastewater that is typically very costly to treat. EBR requires substantial further development work before it will be ready for operational deployment.

I saw something about it on Youtube, and if this thing works, then watch out – SAV will be a billion dollar company without trying.

Anyhow, I’ll keep on digging and keep on posting; but on face value, this SAV raising is definitely something worth seriously considering.